As of 2025-09-17, the Relative Valuation of Atossa Therapeutics Inc (ATOS) is (1.59) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.82 USD, the upside of Atossa Therapeutics Inc based on Relative Valuation is -293.4%.
The range of the Relative Valuation is (0.73) - (2.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.3x - 11.1x | 7.2x |
| Forward P/E multiples | 3.2x - 11.0x | 7.1x |
| Fair Price | (0.73) - (2.45) | (1.59) |
| Upside | -189.3% - -397.5% | -293.4% |
| Date | P/E |
| 2025-09-15 | -3.68 |
| 2025-09-12 | -3.78 |
| 2025-09-11 | -3.70 |
| 2025-09-10 | -3.59 |
| 2025-09-09 | -3.63 |
| 2025-09-08 | -3.63 |
| 2025-09-05 | -3.54 |
| 2025-09-04 | -3.47 |
| 2025-09-03 | -3.46 |
| 2025-09-02 | -3.44 |
| 2025-08-29 | -3.43 |
| 2025-08-28 | -3.39 |
| 2025-08-27 | -3.43 |
| 2025-08-26 | -3.49 |
| 2025-08-25 | -3.42 |
| 2025-08-22 | -3.50 |
| 2025-08-21 | -3.35 |
| 2025-08-20 | -3.32 |
| 2025-08-19 | -3.37 |
| 2025-08-18 | -3.55 |
| 2025-08-15 | -3.49 |
| 2025-08-14 | -3.51 |
| 2025-08-13 | -3.53 |
| 2025-08-12 | -3.48 |
| 2025-08-11 | -3.43 |
| 2025-08-08 | -3.54 |
| 2025-08-07 | -3.47 |
| 2025-08-06 | -3.54 |
| 2025-08-05 | -3.62 |
| 2025-08-04 | -3.75 |
| 2025-08-01 | -3.70 |
| 2025-07-31 | -3.75 |
| 2025-07-30 | -3.92 |
| 2025-07-29 | -4.16 |
| 2025-07-28 | -3.68 |
| 2025-07-25 | -3.78 |
| 2025-07-24 | -3.88 |
| 2025-07-23 | -3.99 |
| 2025-07-22 | -3.87 |
| 2025-07-21 | -3.82 |
| 2025-07-18 | -3.79 |
| 2025-07-17 | -3.91 |
| 2025-07-16 | -4.01 |
| 2025-07-15 | -4.11 |
| 2025-07-14 | -4.21 |
| 2025-07-11 | -4.22 |
| 2025-07-10 | -3.99 |
| 2025-07-09 | -4.05 |
| 2025-07-08 | -3.81 |
| 2025-07-07 | -3.80 |